Arsalan Arif
Publisher and Co-Founder at Endpoints News
Publisher at Endpoints News Health Tech
Founder/CEO, Endpoints News (@endpts), a Financial Times company
Articles
-
Sep 1, 2024 |
mdpi.com | Yousaf Ali |Syed Shah |Arsalan Arif |Mehdi Tlija
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
May 23, 2024 |
mdpi.com | Arsalan Arif |Qasim Ali |Asif Hussain |Farhan Arif
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Sep 29, 2023 |
endpts.com | Arsalan Arif
Japan’s clinical trial landscape has vastly expanded over the last 30 years and CMIC has been at the forefront of the country’s evolution in drug development. In the 80s, as foreign companies faced difficulties entering the Japanese market, CEO and founder Kazuo Nakamura saw opportunities to convert his consultancy business into Japan’s first CRO in 1992. As customer needs expanded, CMIC also adapted, later adding CDMO, SMO and CSO arms to the group.
-
Jun 12, 2023 |
matec-conferences.org | Arsalan Arif
-
Jul 21, 2022 |
endpts.com | Arsalan Arif
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 6K
- Tweets
- 8K
- DMs Open
- Yes
RT @bscholl: We offered pre brief interviews to both WSJ and NYT and invited both to come watch the flight. WSJ said supersonic isn't newsw…
RT @jackshafer: @davidfolkenflik The publisher should never be the story.
RT @JohnCendpts: Had a great conversation on overcoming obstacles to rare disease research with George Demetri, Janet Woodcock, John Connol…